Author:
Soedarsono Soedarsono,Riadi Agustinus Rizki Wirawan
Abstract
Effective tuberculosis (TB) treatment requires a combination of bactericidal and/or bacteriostatic TB drugs. The combination of these regimens is the standard therapy recommended by World Health Organization (WHO). The standard therapy consists of 5 first-line anti-TB drugs (isoniazid, rifampicin, pyrazinamide, ethambutol, and streptomycin). TB drugs have mild to severe side effects. Side effects that arise not only cause mortality and morbidity but also cause the cessation of treatment with the effect of not achieving cure, even arising drug resistance. Drug-induced liver injury (DILI) is a form of side effect that causes the cessation of TB treatment or regimen changes due to treatment failure, relapse, and drug resistance. DILI increases the problem, covering more than 7% of all side effects. DILI is also one of the concerns in the treatment of TB.
Reference17 articles.
1. Maeda R, Isowa N, Kawasaki Y, et al. [Pseudomesotheliomatous Carcinoma of the Lung]. Kyobu Geka the Japanese Journal of Thoracic Surgery. 2007; 60: 555-558.
2. Analysis of Asbestos Concentration in 20 Cases of Pseudomesotheliomatous Lung Cancer;Dodson;Ultrastructural Pathology,2015
3. A Variant of Peripheral Lung Cancer;TR;American Journal of Clinical Pathology,1976
4. Dunitz M. In: Robinson BWS and Chahinian AP, (Eds.). Mesothelioma. London: Martin Dunitz Ltd., Taylor & Francis Group. 2005; 1-93.
5. Domestic Asbestos Exposure: A Review of Epidemiologic and Exposure Data;Goswami;Int J Environ Res Public Health,2013
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献